| Literature DB >> 33266245 |
Ina Thon Aamodt1,2,3, Anna Strömberg4,5, Ragnhild Hellesø2, Tiny Jaarsma4, Irene Lie1.
Abstract
Self-care monitoring at home can be a challenge for patients with heart failure (HF). Tools that leverage information and communication technology (ICT), comprise medical devices, or have written material may support their efforts at home. The aim of this study was to describe HF patients' experiences and their prioritization of tools that support, or could support, self-care monitoring at home. A descriptive qualitative design employing semi-structured interviews was used with HF patients living at home and attending an HF outpatient clinic in Norway. We used a deductive analysis approach, using the concept of self-care monitoring with ICT tools, paper-based tools, medical devices, and tools to consult with healthcare professionals (HCPs) as the categorization matrix. Nineteen HF patients with a mean age of 64 years participated. ICT tools are used by individual participants to identify changes in their HF symptoms, but are not available by healthcare services. Paper-based tools, medical devices, and face-to-face consultation with healthcare professionals are traditional tools that are available and used by individual participants. HF patients use traditional and ICT tools to support recognizing, identifying, and responding to HF symptoms at home, suggesting that they could be used if they are available and supplemented by in-person consultation with HCPs.Entities:
Keywords: eHealth; heart failure; information and communication technology (ICT); mHealth; self-care; telemedicine
Year: 2020 PMID: 33266245 PMCID: PMC7731418 DOI: 10.3390/ijerph17238916
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1A graphic illustration of tools presented to participants: a diary, weighing scale, blood pressure monitor, warning sign pamphlet, mobile phone application, telephone consultation, lung fluid measuring vest, video consultation, face-to face consultation with HCPs, and suggestions from participants’ of other potential tools to be of support.
Results of the deductive analysis, including examples of units of analysis under each predetermined tool category in the categorization matrix.
| Self-care monitoring |
|
|
|
| Paper-based tools to identify HF symptoms | Diary | Male, 60 years, high school, welfare. | |
| Warning signs | Male, 59 years, college, work. | ||
| Medical devices to identify HF symptoms | Weighing scale | Female, 77 years, university, retired. | |
| Vest measuring lung fluid | Male, 60 years, high school, welfare. | ||
| mHealth to identify HF symptoms | Smartphone App | Female, 62 years, college, welfare. | |
| Tools to consult with HCPs to identify HF symptoms | Face to face | Male, 59 years, college, welfare. | |
| Telephone | Male, 72 years, university, retired. | ||
| Video consultation | Male, 78 years, college, retired. |
Abbreviations: HF, heart failure; HCPs, healthcare professionals; ICT, information and communication technology. Translated from the original Norwegian into English.
Participant demographics, HF characteristics, and ICT experience (n = 19).
| Characteristics |
| |
|---|---|---|
| Demographic | Gender | |
| Female | 3 | |
| Male | 16 | |
| Highest education level | ||
| High school | 8 | |
| College/University | 11 | |
| Current work status | ||
| Retired or welfare | 15 | |
| Work fulltime | 4 | |
| Clinical | NYHA class | |
| NYHA 1 | 1 | |
| NYHA 2 | 11 | |
| NYHA 3 | 5 | |
| NYHA 4 | 2 | |
| HF Medications | ||
| ACEI/ARB | 19 | |
| Betablockers | 18 | |
| Diuretics | 17 | |
| Mineral corticoids | 12 | |
| HF Device therapy a | 8 | |
| Comorbidities | 18 | |
| ICT Experience | Experience of using | |
| Internet at home | 18 | |
| 18 | ||
| E-mail on smartphone | 11 |
Abbreviations: ICT, information and communication technology; NYHA class, New York Heart Association Functional Classification. ACEI, angiotensin converting enzyme inhibitors. ARB, angiotensin receptor blockers. a Cardiac resynchronization therapy with pacemaker or defibrillator, implantable cardioverter-defibrillator.